21.42500 EUR
2.411
12.68%
Last update Dec 18, 3:33 PM CET
Main market
Day range
21.42500
22.18000
Previous close
19.014000
Open
22.18000
Access this stock data via API
Subscribe
Apellis Pharmaceuticals Inc.
21.43
2.41
12.68%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024
Total reported revenue 666.1M
Cost of revenue 100.4M
Gross profit 565.7M
Operating expense
Research & development 279.3M
Selling general and admin 427.1M
Other operating expenses
Operating income -140.6M
Non operating interest income
Income 10.9M
Expense 34.4M
Other income expense -3.5M
Pretax income -167.7M
Tax provision 990.6K
Net income -168.7M
Basic EPS -1.6
Diluted EPS -1.6
Basic average shares 105.6M
Diluted average shares 105.6M
EBITDA -130.1M
Net income from continuing op. -168.7M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 26 minutes

10:03
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).